Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weinstein

Showing results (421-430 of 611) with videos related to

Pageof 62
Sort By:
Annals of Internal Medicine|May 20, 2000
Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristicsL A Prosser, A A Stinnett, P A Goldman, et al.
International Journal of Technology Assessment in Health Care|June 30, 2000
The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDSJ A Scharfstein, A D Paltiel, M C Weinstein, et al.
Neurology|November 4, 2000
A new mutation in the prion protein gene: a patient with dementia and white matter changesB van Harten, W A van Gool, I M Van Langen, et al.
Health Economics|November 14, 1997
Productivity costs, time costs and health-related quality of life: a response to the Erasmus GroupM C Weinstein, J E Siegel, A M Garber, et al.
The New England Journal of Medicine|July 2, 1992
Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarctionH M Krumholz, R C Pasternak, M C Weinstein, et al.
Tijdschrift Voor Gerontologie En Geriatrie|August 1, 1991
[CAMDEX-N: the Dutch version of the Cambridge Examination for Mental Disorders of the Elderly with automatic data processing]M M Derix, A B Hofstede, S Teunisse, et al.
Journal of Medical Economics|November 14, 2023
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United StatesMichele A Kohli, Michael Maschio, Keya Joshi, et al.
Pharmacoeconomics|March 6, 2026
Component Clinical and Cost Outcomes Complementing Value of Information: Case Study of a Tuberculosis Diagnostics Clinical TrialPamela Pei, Livia Qoshe, Grady Florance, et al.
Annals of Internal Medicine|December 6, 2006
Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costsA David Paltiel, Rochelle P Walensky, Bruce R Schackman, et al.
Plos One|September 11, 2013
Cost-effectiveness analysis of Tdap in the prevention of pertussis in the elderlyLisa J McGarry, Girishanthy Krishnarajah, Gregory Hill, et al.
Pageof 62

Showing results (421-430 of 611) with videos related to

Sort By:
Pageof 62
Annals of Internal Medicine|May 20, 2000
Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristicsL A Prosser, A A Stinnett, P A Goldman, et al.
International Journal of Technology Assessment in Health Care|June 30, 2000
The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDSJ A Scharfstein, A D Paltiel, M C Weinstein, et al.
Neurology|November 4, 2000
A new mutation in the prion protein gene: a patient with dementia and white matter changesB van Harten, W A van Gool, I M Van Langen, et al.
Health Economics|November 14, 1997
Productivity costs, time costs and health-related quality of life: a response to the Erasmus GroupM C Weinstein, J E Siegel, A M Garber, et al.
The New England Journal of Medicine|July 2, 1992
Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarctionH M Krumholz, R C Pasternak, M C Weinstein, et al.
Tijdschrift Voor Gerontologie En Geriatrie|August 1, 1991
[CAMDEX-N: the Dutch version of the Cambridge Examination for Mental Disorders of the Elderly with automatic data processing]M M Derix, A B Hofstede, S Teunisse, et al.
Journal of Medical Economics|November 14, 2023
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United StatesMichele A Kohli, Michael Maschio, Keya Joshi, et al.
Pharmacoeconomics|March 6, 2026
Component Clinical and Cost Outcomes Complementing Value of Information: Case Study of a Tuberculosis Diagnostics Clinical TrialPamela Pei, Livia Qoshe, Grady Florance, et al.
Annals of Internal Medicine|December 6, 2006
Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costsA David Paltiel, Rochelle P Walensky, Bruce R Schackman, et al.
Plos One|September 11, 2013
Cost-effectiveness analysis of Tdap in the prevention of pertussis in the elderlyLisa J McGarry, Girishanthy Krishnarajah, Gregory Hill, et al.
Pageof 62